These results suggest that HBM‐Exo might inhibit IL‐17 signalling pathway, inhibit cell apoptosis and reducing AT‐II cell damage, thus playing a role in the prevention and treatment of BPD. Here, IL17A is linked to bronchopulmonary dysplasia.